Draft — For practitioner review only · Version 0.1 · July 2026
03.02 Unit 2 of 4 The DEJ & the dermis
Depth
0 of 3 committed

Unit 2 · The DEJ & the dermis

The junction that ages first, and the scaffold that ages with it

This unit covers the interface holding epidermis to dermis, then the connective tissue scaffold beneath it. By the end you should be able to explain why the dermal–epidermal junction is a functional structure rather than a boundary line, and which dermal cell and layer a given treatment or complication is actually acting on.

  • ~8 minutes
  • 3 checkpoints
  • Level: All practitioners — tiered content

Learn · The dermal–epidermal junction

An interface, not a boundary line

The dermal–epidermal junction (DEJ), also called the basement membrane zone, is the structural interface between the avascular epidermis and the vascularised dermis.

It is a specialised extracellular matrix approximately 0.5–1 µm thick, comprising four distinct zones visible on electron microscopy: the basal keratinocyte plasma membrane, the lamina lucida, the lamina densa, and the sub-lamina densa zone. Key structural components include laminin-332 within the lamina lucida, collagen IV forming the lamina densa network, and anchoring fibrils composed of collagen VII extending into the papillary dermis. These components anchor the epidermis to the dermis and are essential for skin integrity.

Predict, then reveal

In young skin, the DEJ is characterised by prominent rete ridges — interdigitating projections of the epidermis extending down into the dermis. Before reading on, predict what happens to mechanical adhesion and to the epidermis's capacity to renew itself as those ridges flatten with age and UV exposure.

Hold your answer before you open this. The value is in having committed to a mechanism first.

Advanced detail

More pronounced flattening occurs with photoageing than with intrinsic ageing alone: subepidermal elastosis progressively replaces DEJ integrity in chronically sun-exposed skin, compounding the adhesion loss seen with chronological ageing alone.

Checkpoint 01 Awaiting commitment

The dermal–epidermal junction anchors the epidermis to the dermis primarily through:

Select an option to commit. The reasoning appears afterwards.

Learn · The dermis

Two sub-layers, two very different clinical targets

The dermis is the structural scaffold of the skin — a connective tissue layer that provides tensile strength, elasticity, hydration, and vascular and neural supply to the overlying epidermis. It is the primary target of most energy-based aesthetic devices, injectable fillers, and collagen-stimulating treatments. Its two sub-layers — the papillary and reticular dermis — have distinct properties and respond differently to ageing and treatment.

Papillary and reticular dermis compared
Attribute Papillary dermis Reticular dermis
Location & extent Immediately below the DEJ; thin, loosely arranged — 0.1–0.2 mm Below the papillary dermis; bulk of the dermis — 1–4 mm facial
Composition Thin collagen I/III fibres, fine elastic fibres, fibroblasts, mast cells, macrophages, a rich subepidermal capillary plexus Thick collagen I bundles (80% of dry weight), collagen III, variable-diameter elastic fibres, hair follicles, sebaceous and sweat glands, deep vascular plexus
Function Nutrient supply to the avascular epidermis by diffusion; fingerprint pattern formation; fine touch sensation via Meissner's corpuscles Tensile strength, elasticity and recoil; hyaluronic acid ground substance binds water; hair cycling, sebum and sweat originate here
Aesthetic relevance Primary zone for superficial resurfacing (light peels, non-ablative lasers, low-density fractional RF); mast cells release histamine on energy stimulation, producing post-treatment erythema and urticaria Principal target of collagen-stimulating treatments — ablative and non-ablative lasers, radiofrequency, HIFU, microneedling; fibroblasts are the key effector cell; deep filler placement replicates the natural GAG scaffold
Checkpoint 02 Awaiting commitment

You want to explain to a colleague why an energy-based device stimulates new collagen rather than simply heating the skin. The cell type responsible for collagen I/III and elastin synthesis in the dermis, and the key effector cell of these treatments, is the:

Select an option to commit. The reasoning appears afterwards.

Learn · Collagen subtypes

Why type I and type III are not interchangeable

Advanced detail

Type I collagen comprises 80–85% of dermal collagen and provides tensile strength. Type III collagen (15–20%) is more elastic and predominates in fetal skin and early wound repair. The ratio of type I to type III shifts with ageing — type III proportionally increases as total collagen content declines, producing the characteristic laxity of aged skin despite apparent fibrous density on histology. Collagen-stimulating treatments preferentially upregulate type I collagen synthesis — their primary mechanism of clinical benefit. Collagen I synthesis requires adequate substrate: vitamin C (ascorbic acid) is an essential cofactor for prolyl and lysyl hydroxylases, enzymes critical to collagen triple-helix stabilisation — the mechanistic rationale for topical vitamin C in post-treatment skincare.

Checkpoint 03 Awaiting commitment

A patient develops localised erythema and urticaria within minutes of a fractional laser treatment. This reaction is most directly explained by activation of:

Select an option to commit. The reasoning appears afterwards.

Unit 2 summary

Clinical takeaways

  1. The DEJ is a functional anchoring structure, not a boundary line. Laminin-332, collagen IV and collagen VII anchoring fibrils create the adhesion complex between epidermis and dermis.
  2. Rete ridge flattening with age and UV exposure weakens that adhesion. It reduces DEJ surface area, increases susceptibility to shearing, and reduces the basal proliferative surface — contributing to epidermal thinning. Retinoids, fractional laser and microneedling partially restore it.
  3. Papillary and reticular dermis are functionally distinct. Papillary dermis nourishes the epidermis and houses mast cells; reticular dermis provides tensile strength via collagen I/III and is the target of most collagen-stimulating treatments.
  4. Fibroblasts are the key effector cell of dermal collagen synthesis. Vitamin C is an essential cofactor for collagen stabilisation — the mechanistic basis for topical vitamin C post-treatment.